Related Experiment Video

Updated: Jul 10, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Platelets, arterial thrombosis and cerebral ischemia

Lina Badimon1, Gemma Vilahur

  • 1Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain. LBadimon@csic-iccc.org

Cerebrovascular Diseases (Basel, Switzerland)
|November 29, 2007
PubMed

Insights

Atherosclerosis is a progressive arterial disease leading to atherothrombosis. Antiplatelet drugs are crucial in preventing atherothrombotic events by targeting platelet activity.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Pharmacology

Background:

  • Atherosclerosis is a systemic, lifelong disease that progresses asymptomatically until clinical manifestation.
  • Atherothrombosis, a consequence of atherosclerosis, underlies major cardiovascular events like heart attack and stroke.
  • Recent research has significantly advanced the understanding of atherothrombotic disease pathophysiology.

Purpose of the Study:

  • To elucidate the pathophysiology of atherothrombotic disease.
  • To highlight the role of atherosclerosis progression in clinical manifestations.
  • To emphasize the importance of platelets in atherothrombotic events.

Main Methods:

  • Review of experimental, clinical, and pathological investigations.
  • Analysis of large-scale clinical trials on antiplatelet therapy.
  • Pathophysiological examination of plaque disruption and thrombus formation.

Main Results:

  • Atherosclerosis progresses silently, leading to atherothrombosis.
  • Plaque rupture and subsequent thrombus formation are key mechanisms.
  • Antiplatelet drugs significantly reduce nonfatal atherothrombotic events.

Conclusions:

  • Platelets play a critical role in arterial atherothrombosis.
  • Understanding atherosclerosis progression is vital for managing atherothrombotic disease.
  • Antiplatelet therapy is a cornerstone in preventing atherothrombotic complications.

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...